1036 related articles for article (PubMed ID: 28124606)
1. Cytochrome P450 Structure, Function and Clinical Significance: A Review.
Manikandan P; Nagini S
Curr Drug Targets; 2018; 19(1):38-54. PubMed ID: 28124606
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanisms of cytochrome p450 induction: potential for drug-drug interactions.
Jana S; Paliwal J
Curr Protein Pept Sci; 2007 Dec; 8(6):619-28. PubMed ID: 18220847
[TBL] [Abstract][Full Text] [Related]
3. Cytochrome P450 Enzymes and Drug Metabolism in Humans.
Zhao M; Ma J; Li M; Zhang Y; Jiang B; Zhao X; Huai C; Shen L; Zhang N; He L; Qin S
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884615
[TBL] [Abstract][Full Text] [Related]
4. Polymorphism of human cytochrome P450 enzymes and its clinical impact.
Zhou SF; Liu JP; Chowbay B
Drug Metab Rev; 2009; 41(2):89-295. PubMed ID: 19514967
[TBL] [Abstract][Full Text] [Related]
5. Role of CYP pharmacogenetics and drug-drug interactions in the efficacy and safety of atypical and other antipsychotic agents.
Murray M
J Pharm Pharmacol; 2006 Jul; 58(7):871-85. PubMed ID: 16805946
[TBL] [Abstract][Full Text] [Related]
6. Novel advances in cytochrome P450 research.
Singh D; Kashyap A; Pandey RV; Saini KS
Drug Discov Today; 2011 Sep; 16(17-18):793-9. PubMed ID: 21864709
[TBL] [Abstract][Full Text] [Related]
7. Human cytochrome P450 enzymes 5-51 as targets of drugs and natural and environmental compounds: mechanisms, induction, and inhibition - toxic effects and benefits.
Rendic SP; Peter Guengerich F
Drug Metab Rev; 2018 Aug; 50(3):256-342. PubMed ID: 30717606
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic Mechanisms Contribute to Intraindividual Variations of Drug Metabolism Mediated by Cytochrome P450 Enzymes.
Jin J; Zhong XB
Drug Metab Dispos; 2023 Jun; 51(6):672-684. PubMed ID: 36973001
[TBL] [Abstract][Full Text] [Related]
9. Advances in molecular modeling of human cytochrome P450 polymorphism.
Martiny VY; Miteva MA
J Mol Biol; 2013 Nov; 425(21):3978-92. PubMed ID: 23856621
[TBL] [Abstract][Full Text] [Related]
10. Inhibition and induction of cytochrome P450 and the clinical implications.
Lin JH; Lu AY
Clin Pharmacokinet; 1998 Nov; 35(5):361-90. PubMed ID: 9839089
[TBL] [Abstract][Full Text] [Related]
11. The current understanding of the interactions between nanoparticles and cytochrome P450 enzymes - a literature-based review.
Pan Y; Ong CE; Pung YF; Chieng JY
Xenobiotica; 2019 Jul; 49(7):863-876. PubMed ID: 30028220
[TBL] [Abstract][Full Text] [Related]
12. Inhibition and induction of CYP enzymes in humans: an update.
Hakkola J; Hukkanen J; Turpeinen M; Pelkonen O
Arch Toxicol; 2020 Nov; 94(11):3671-3722. PubMed ID: 33111191
[TBL] [Abstract][Full Text] [Related]
13. Genetic polymorphism of metabolic enzymes P450 (CYP) as a susceptibility factor for drug response, toxicity, and cancer risk.
Bozina N; Bradamante V; Lovrić M
Arh Hig Rada Toksikol; 2009 Jun; 60(2):217-42. PubMed ID: 19581216
[TBL] [Abstract][Full Text] [Related]
14. Clinically important drug interactions potentially involving mechanism-based inhibition of cytochrome P450 3A4 and the role of therapeutic drug monitoring.
Zhou SF; Xue CC; Yu XQ; Li C; Wang G
Ther Drug Monit; 2007 Dec; 29(6):687-710. PubMed ID: 18043468
[TBL] [Abstract][Full Text] [Related]
15. The effects of cytochrome P450 induction by xenobiotics on endobiotic metabolism in pre-clinical safety studies.
Amacher DE
Toxicol Mech Methods; 2010 May; 20(4):159-66. PubMed ID: 20218941
[TBL] [Abstract][Full Text] [Related]
16. Computational prediction of cytochrome P450 inhibition and induction.
Kato H
Drug Metab Pharmacokinet; 2020 Feb; 35(1):30-44. PubMed ID: 31902468
[TBL] [Abstract][Full Text] [Related]
17. [From the Viewpoint of Drug Metabolism Research].
Nakajima M
Yakugaku Zasshi; 2017; 137(6):697-705. PubMed ID: 28566576
[TBL] [Abstract][Full Text] [Related]
18. Cytochrome P450 enzyme isoforms and their therapeutic implications: an update.
Kalra BS
Indian J Med Sci; 2007 Feb; 61(2):102-16. PubMed ID: 17259690
[TBL] [Abstract][Full Text] [Related]
19. The Human Cytochrome P450 (CYP) Allele Nomenclature website: a peer-reviewed database of CYP variants and their associated effects.
Sim SC; Ingelman-Sundberg M
Hum Genomics; 2010 Apr; 4(4):278-81. PubMed ID: 20511141
[TBL] [Abstract][Full Text] [Related]
20. Cytochrome P450 polymorphism--molecular, metabolic, and pharmacogenetic aspects. II. Participation of CYP isoenzymes in the metabolism of endogenous substances and drugs.
Tomaszewski P; Kubiak-Tomaszewska G; Pachecka J
Acta Pol Pharm; 2008; 65(3):307-18. PubMed ID: 18646550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
